Polish biotechnology company headquartered in Gdańsk with sites at Warsaw, Duchnice and Utrecht in the Netherlands, part of the Polpharma group. Develops and manufactures biological medicines, with a portfolio of biosimilar monoclonal antibodies and a contract development and manufacturing business offering cell line development, process and analytical development, and clinical and commercial scale mammalian cell culture manufacturing and fill finish for biosimilars and innovative biologics.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen